Similar Articles
881 Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after surgery: A comment for moving forward
882 Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model
883 Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohort
884 Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study
885 Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
886 High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation
887 Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma
888 Hepatocellular carcinoma: Review of disease and tumor biomarkers
889 Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma
890 Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA